Sound Income Strategies, LLC Gilead Sciences, Inc. Transaction History

Sound Income Strategies, LLC

$1.4 Billion
Q3 2024

A detailed history of Sound Income Strategies, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sound Income Strategies, LLC holds 146 shares of GILD stock, worth $13,337. This represents 0.0% of its overall portfolio holdings.

Number of Shares

146

Previous 349 58.17%

Holding current value

$13,337

Previous $23,000 47.83%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$66.59 - $83.99 $13,517 - $17,049	-203 Reduced 58.17%	146 $12,000
Q2 2024 Jul 12, 2024	BUY	$63.15 - $72.88 $3,725 - $4,299	59 Added 20.34%	349 $23,000
Q1 2024 Apr 15, 2024	SELL	$71.58 - $87.29 $20,400 - $24,877	-285 Reduced 49.57%	290 $21,000
Q4 2023 Jan 10, 2024	BUY	$73.27 - $83.09 $27,183 - $30,826	371 Added 181.86%	575 $46,000
Q3 2023 Oct 12, 2023	SELL	$73.94 - $80.67 $2,070 - $2,258	-28 Reduced 12.07%	204 $15,000
Q2 2023 Jul 10, 2023	SELL	$76.01 - $86.7 $58,679 - $66,932	-772 Reduced 76.89%	232 $17,000
Q4 2022 Jan 11, 2023	BUY	$62.32 - $89.47 $560 - $805	9 Added 0.9%	1,004 $0
Q3 2022 Oct 18, 2022	SELL	$59.54 - $68.01 $5,537 - $6,324	-93 Reduced 8.55%	995 $61,000
Q2 2022 Jul 11, 2022	BUY	$57.72 - $65.01 $3,059 - $3,445	53 Added 5.12%	1,088 $67,000
Q4 2021 Jan 13, 2022	SELL	$64.88 - $73.64 $9,148 - $10,383	-141 Reduced 11.99%	1,035 $75,000
Q3 2021 Oct 12, 2021	BUY	$67.69 - $73.03 $10,153 - $10,954	150 Added 14.62%	1,176 $82,000
Q2 2021 Jul 13, 2021	SELL	$63.47 - $69.35 $39,414 - $43,066	-621 Reduced 37.7%	1,026 $71,000
Q1 2021 Apr 14, 2021	SELL	$60.0 - $68.46 $480 - $547	-8 Reduced 0.48%	1,647 $106,000
Q4 2020 Jan 11, 2021	BUY	$56.65 - $64.55 $13,029 - $14,846	230 Added 16.14%	1,655 $96,000
Q3 2020 Oct 08, 2020	BUY	$62.1 - $78.08 $4,533 - $5,699	73 Added 5.4%	1,425 $90,000
Q2 2020 Jul 13, 2020	BUY	$72.34 - $84.0 $20,689 - $24,024	286 Added 26.83%	1,352 $104,000
Q1 2020 Apr 07, 2020	BUY	$62.63 - $80.22 $52,671 - $67,465	841 Added 373.78%	1,066 $80,000
Q4 2019 Jan 06, 2020	BUY	$61.62 - $67.78 $61 - $67	1 Added 0.45%	225 $15,000
Q3 2019 Oct 04, 2019	BUY	$62.51 - $69.0 $62 - $69	1 Added 0.45%	224 $14,000
Q2 2019 Jul 16, 2019	SELL	$61.87 - $69.38 $4,763 - $5,342	-77 Reduced 25.67%	223 $15,000
Q1 2019 Apr 04, 2019	BUY	$62.53 - $70.05 $62 - $70	1 Added 0.33%	300 $20,000
Q4 2018 Jan 11, 2019	BUY	$60.54 - $79.0 $60 - $79	1 Added 0.34%	299 $19,000
Q3 2018 Oct 03, 2018	SELL	$71.28 - $78.92 $570 - $631	-8 Reduced 2.61%	298 $23,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $908 - $1,059	14 Added 4.79%	306 $22,000
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $13,693 - $16,694	188 Added 180.77%	292 $22,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $7,399 - $8,686	104	104 $8,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sound Income Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sound Income Strategies, LLC with notifications on news.

Account

Sound Income Strategies, LLC Gilead Sciences, Inc. Transaction History